Literature DB >> 8915158

Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands.

V García-Patos1, R Bartralot, V Fonollosa, C Arnal, M Boronat, C Gelpí, J L Rodríguez, A Castells.   

Abstract

We report a boy with overlap manifestations of systemic sclerosis and dermatomyositis (sclerodermatomyositis) whose disease showed a changing clinical pattern, and who had mechanic's hands, which are a cutaneous marker of myositis. Serological studies revealed antinuclear antibodies with a homogeneous nucleolar pattern. The anti-PM-Scl antibody was demonstrated by immunoblotting. HLA typing was positive for HLA-DR3/4. After a follow-up period of 11 years, no progression to severe systemic involvement was detected, and aggressive treatment was not administered. The recognition of subsets of patients with homogeneous clinical features and serological markers should permit the recognition of separate conditions among overlap syndromes. This would have prognostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915158

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.

Authors:  Lisbeth Aranbicia Aguila; Michelle Remião Ugolini Lopes; Flavia Zon Pretti; Percival Degrava Sampaio-Barros; Fernando Henrique Carlos de Souza; Eduardo Ferreira Borba; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2014-07-04       Impact factor: 2.980

2.  Mechanic's hands revisited: is this sign still useful for diagnosis in patients with lung involvement of collagen vascular diseases?

Authors:  Erei Sohara; Takeshi Saraya; Shinji Sato; Naoki Tsujimoto; Takayasu Watanabe; Saori Takata; Yasutaka Tanaka; Haruyuki Ishii; Hajime Takizawa; Hajime Goto
Journal:  BMC Res Notes       Date:  2014-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.